Advertisement
U.S. markets closed

China Jo-Jo Drugstores, Inc. (CJJD)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
2.91000.0000 (0.00%)
At close: 04:00PM EDT
2.9800 +0.07 (+2.41%)
After hours: 05:46PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close2.9100
Open2.8500
Bid2.9300 x 800
Ask3.0300 x 1000
Day's Range2.8500 - 3.0100
52 Week Range2.3900 - 95.8000
Volume15,144
Avg. Volume77,185
Market Cap4.897M
Beta (5Y Monthly)-0.10
PE Ratio (TTM)N/A
EPS (TTM)-41.4000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CJJD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • China Jo-Jo Drugstores, Inc.
    Weekly Stock ListWe see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.
    Rating
    Fair Value
    Economic Moat
    16 hours agoArgus Research
View more
  • PR Newswire

    China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split

    China Jo-Jo Drugstores, Inc. (the "Company") (Nasdaq: CJJD), a Cayman Islands exempted company, reported that it expects to implement a 1-for-20 reverse stock split on its ordinary shares ("Ordinary Shares") effective Friday, March 1, 2024, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the Ordinary Shares will continue on the Nasdaq Capital Market under the symbol "CJJD". The new CUSIP number for the Ordinary Shares following the reverse stock split i

  • PR Newswire

    China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement

    China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on December 13, 2023, the Company received another 180 calendar day extension from Nasdaq's Listing Qualifications Department ("Nasdaq") to meet Nasdaq's continuing listing requirements by maintaining a minimum bid price per share of $1.00 for a minimum of 10 consecutive

  • PR Newswire

    China Jo-Jo Drugstores Announces Celebration of its 20th Anniversary

    China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that its 20th Anniversary Ceremony (the "Ceremony") was held in Hangzhou. The Ceremony not only marks a milestone in the Company's history, but also heralds a new chapter for its future growth.